ABSTRACT To assess the best method of quantitating progression of coronary disease, we studied four measurements in 114 coronary segments from 35 medically treated patients from whom angiograms were obtained 5 years apart. Only stenoses of less than 70% that were visualized in nearly identical projections on both angiograms were evaluated. Vessel edges were measured by use of catheter calibration and an automated computer algorithm yielding two "absolute dimensions" (mean and minimum diameters) and two measurements (percent stenosis and atheroma area) that required a "normal reference" diameter. The coefficient of variation for repeated segment measurements was less for mean and minimum diameter than for percent stenosis and area of atheroma. The best measure of progression of coronary disease as determined by t test comparison of different methods was the change in mean diameter over time (6.7 14.1% decrease), whether calculated on a per coronary segment or per patient basis (p < .001). Based on this measurement and its standard deviation of progression of coronary disease in this patient subset with relatively benign disease, it is estimated that 470 patients per group would be required for an interventional study to demonstrate a 33% reduction in disease progression (207 patients for 50% reduction) at a 95% confidence level and 90% power. Circulation 74, No. 6, 1235No. 6, -1242No. 6, , 1986 CLINICAL TRIALS testing interventions aimed at slowing the advance of coronary artery disease require accurate and reproducible methods of determining the rate of disease progression to assess results.
CLINICAL TRIALS testing interventions aimed at slowing the advance of coronary artery disease require accurate and reproducible methods of determining the rate of disease progression to assess results.
Most previous trials have used myocardial infarction and cardiac death as end points. However, due to their low occurrence rate and delay in response to intervention, the use of these end points requires that numerous subjects be followed over a long period of time to demonstrate an effect.1'-It has therefore been suggested that quantitative angiographic measurements that might be more sensitive to intervention be used as a standard. Several investigations using visually assessed change in percent coronary stenosis have been conducted,13 but shortcomings of this measurement are well recognized and interobserver variability for each determination of percent coronary stenosis ranges from 5% to 18%.1&16
Investigators have partially overcome these shortcomings with the use of Vernier calipers,17' 18 computerized edge detection,1>22 or photodensitometry.23 24 However, any determination of severity of stenosis referenced to an adjacent "normal" artery may be inherently unreliable because of the diffuse nature of coronary artery disease. 25 Absolute luminal diameter may be a better measure. 26 There is little information available comparing different methods for quantitating progression of coronary artery disease that would provide a basis for estimating the sample sizes required to demonstrate alterations in rates of progression resulting from various interventions. We therefore compared the rates and variability of progression of coronary artery dis-ease as assessed by several measurements of coronary arterial dimensions in patients who had received medical treatment for 4 to 6 years.
Methods
Patient selection. The NHLBI-sponsored Coronary Artery Surgery Study (CASS) is a multi-institution research project consisting of a randomized trial of medical versus surgical treatment for coronary artery disease in patients who underwent diagnostic evaluation for suspected coronary artery disease and were followed for subsequent cardiac events. Angiograms were obtained at study entry in all patients and again 5 years later per protocol requirements.
Of the 57 Stanford University Medical Center and 100 Montreal Heart Institute patients who were randomly assigned treatment as part of the CASS trial, 80 were randomized to medical treatment. Sixty-eight patients of the 80 survived to 5 years and did not have intervening bypass surgery. Thirty-five of the 47 patients who underwent 5 year follow-up angiography met the following entry criteria.
Both the initial and 4 to 6 year follow-up angiograms were of good quality, with at least one coronary segment visualized in "nearly identical" projections on both studies. Segments were required to be visualized on projections that were within an estimated 10 degrees of each other in both the axial and cranial/ caudal angulation in order to be considered "nearly identical." Because this was a retrospective study and because quantitative coronary angiography was not part of the CASS protocol in the mid 1970s, there was no rigorous recording of cine views, angiographic technique, or radiographic imaging variables such as film speed, electrocardiographic marking of cine frames, kilovolts, or milliamps. In some instances different imaging equipment was used to obtain the baseline and 5 year angiograms. Although a visual match was attempted to ensure that segment visualization and measurements were obtained at similar projectional angles, small differences were common. This would manifest itself on paired angiograms as slightly different backgrounds and different crossing background vessels, as well as slight differences in projected lengths of the same segments demarcated by the same fiducial points.
Coronary segments were required to include at least one area of estimated 10% to 69% narrowing on the initial study. It should be emphasized that in most segments, the coronary disease was visualized as marginal irregularities, not as discrete stenoses. A total of 144 segments were identified according to these criteria. Six percent had estimated stenosis of 50% to 69%, 41% had stenosis of between 30% and 49%, and 53% had between 1% and 29% narrowing.
Lesions of 70% or greater were excluded because of concern that the future natural history of these lesions might not reflect primary atherosclerotic processes. Candidate vessels were selected to avoid these severely stenotic segments, which had a reasonably high probability of becoming subject to the manipulations of bypass surgery or angioplasty or of forming thrombus, thus altering their natural history. Moreover, the rate of progression of severe stenoses may be influenced by hemodynamic forces, particularly when a lesion is critical enough to cause a drop in pressure. In addition, thrombotic material may be deposited without necessarily causing total obstruction.
A matter of practical consideration is the fact that patients could be located at the proximal, middle, or distal portion of the segment. The 2.5 cm maximum length was selected to provide adequate optical magnification for the quantizing system, yet remain within the limits of the vertical span of the CRT display. This permits up to a 5 cm gap between fiducial points. In our experience some small branch vessels could not be identified on serial films, even with regard to the right coronary artery, but this was rare. The computer quantitation system also permits chaining together of individual segments based on the termination point of a more proximally quantitated segment.
Both angiograms were obtained without the use of nitroglycerin.
Exact catheter sizes were available for both baseline and 5 year angiograms.
Patients included had treatment limited to "'optimal medical therapy." Specifically, they underwent no coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty involving the qualifying segment or any other segment that might be expected to alter blood flow to the quantitated segment under study. Three patients underwent repeat catheterization for progressive clinical symptoms and 32 patients had follow-up catheterization on a protocol basis.
Angiographic assessment System hardware. Angiograms were reviewed on a Vanguard M35C projector equipped with a three-lens turret thatprovided optical magnification at ratios of 1: 1, 3.7: 1, or 7: 1. A moveable stage permitted the operator to select only a portion of the cine frame for magnification, typically at 3.7: 1. A wideband video camera acquired the selected image in a 512-line format that was then digitized by a DeAnza image processor (480 X 512; eight-bit gray scale).
The typical coronary vessel image was recorded in a 6 inch image intensifier mode with optical magnification of 3.7: 1 such that each digitized pixel covered a true object area of 0.05 mm2, which defines the theoretical limits of hardware resolution. Recordings obtained at image magnification modes higher than 6 inches were generally avoided because of excessive quantum mottle, particularly on older films. Pincushion distortion was corrected by a function defining center-to-edge magnification derived from a previously digitized grid.
Computer-assisted quantitation. The operator used a light pen to approximate the edges of either the catheter or coronary vessel. Using these lines as initial search locations, the automatic edge-finding algorithm drew and smoothed the edges, defining the edge as the peak of the first derivative of the gray-scale density gradient, perpendicular to the long axis of the catheter or vessel as estimated from the operator's initial tracings.2'
The catheter was used as an object of known dimensions providing calibration for measurement of coronary vessels. The actual outside diameter of the catheter was manually entered into the computer for calculation of the magnification factor. Catheter diameters were A 2 mm long region of the catheter diameter just proximal to the distal bend was designated by the operator for computer measurement. Based on the results of the automatic edge finding, the magnification factor for that particular cine film run, i.e., single coronary injection, was computed. In order for a coronary cine run to be quantitated, the catheter had to be visible during a portion of the cine run with only in-plane panning permitted during cine runs.
It is recognized that the distance along the imaging axis between the distal coronary catheter and different portions of the injected coronary arteries may vary quite a bit. In general, for each centimeter change of position of the coronary artery in relation to the image intensifier, there is a 1.0% change in magnification. However, in this study in which similar projections of the same artery in the same patient are being compared over time, this effect is irrelevant unless the heart has substantially changed in size.
Angiographic projections and cine frames were selected to visualize vessel segments as nearly perpendicular as possible to the imaging axis, thus minimizing shortening. End-diastolic frames were selected on the basis of identification of the motion of the heart. In general, this portion of the cardiac cycle maximally spread the coronary vessels away from one another, thus reducing vessel overlap; however, on occasion, earlier diastolic frames were selected out of necessity.
In general, the right coronary artery was best visualized in the 60 degree left anterior oblique (LAO) and 30 degree right anterior oblique (RAO) projections. For the most proximal branches of the left coronary artery, the 20 degree cranial, 70 degree LAO projection proved useful in patients with vertically oriented hearts and the very shallow LAO, anteroposterior, or RAO projections were best for horizontally oriented hearts. Although the caudal LAO view did open up the proximal vessels in patients with horizontally oriented hearts, the image quality and vessel foreshortening rarely permitted quantitation. For visualization of the mid to distal left anterior descending and circumflex arteries, the 20 degree caudal 45 degree RAO projection yielded excellent vessel separation. However, because this study used baseline films acquired between 1974 and 1979 when equipment for angled views was not widely available, the straight axial RAO view was generally the most common available projection. Although 90 degree lateral views were often available, they were of limited utility for quantitation of the left anterior descending artery because of "bum out" due to the radiographic lucency of adjacent lung.
Each coronary segment meeting the entry criteria was traced and the computer defined the segment edges (figure 1). The tracing of the computer-defined segment edges was superimposed on the digitized image of the cine frame, permitting direct assessment of the extent to which adequate margin definition had been accomplished. In areas of crossing vessels and branch points, and particularly areas with dark backgrounds, the computer algorithm would track inappropriately. The operator had the option of selecting any short section of the computer-generated margins to be replaced by manual tracing. At no time did the length of a manually entered margin exceed 20% of the total length of the quantitated segment. ln addition, a computer smoothing algorithm consisting of a 17-word point triangularly weighted moving average was applied to the outline. By, a combination of direct operator monitoring of the quantitation algorithm and smoothing provided by the computer algorithm, aberrant diameter measurements were avoided, thus eliminating the need for any subsequent data exclusions.
The operator was asked by the program to indicate a point of "normal" coronary diameter within the segment, usually that with the maximum diameter. This reference diameter was selected in a manner to avoid areas of ectasia, poststenotic dilatation, and widening of vessels at vessel bifurcations. The reference diameter was selected to be at the same site on the baseline and follow-up arteriograms. However, on occasion, visible disease on the follow-up arteriogram led to selection of a different Vol. 74, No. 6, December 1986 reference point meeting the above criteria. The computer-assisted measurements included: (1) mean segment diameter, (2) minimum segment diameter, (3) maximum percent coronary diameter reduction, and (4) planar area of atheroma = (normal diameter minus the mean diameter) x the segment length.
Segments from the follow-up angiogram were matched with the identical segments on the initial angiogram with the use of fiducial points (usually proximal coronary branches) and computer-measured identical segment lengths. It was recognized that the distance between adjacent fiducial points on paired angiograms would differ slightly, but usually not by more than 10%. In this situation, it was decided to use a fixed length based on the fiducial point on the baseline arteriogram and employ that fixed length on the follow-up arteriogram to calculate the relevant diameters. At no time was an area of visible substantial disease excluded or included as a result of the use of this approach.
Statistical methods. In this analysis two statistical techniques were applied: the coefficient of variation and the paired t test. The coefficient of variation is defined as the ratio of the standard deviation to the mean, measuring the dispersion in the data relative to the absolute value of the measurement. In this study each measurement was repeated by the computer operator for each coronary segment, both at study entry and at follow-up. Related measurements were made on the same cine frames, thus primarily testing the computer quantitation system. However, reproducibility of operator definition of fiducial points, the reference margin for calculating percent stenosis, and manual override of the automatic edge-finding algorithm were included in this evaluation. The standard deviation and mean were calculated for these values, and the coefficient of variation was computed for each segment. These were averaged over all segments to provide a mean coefficient of variation (table 1) .
For the remainder of this analysis, the two repeated measurements from each vessel were averaged, and the average was treated as a single data point. The change over the 5 year interval was investigated by comparing the values after 5 years with the initial values. This was done both in terms of absolute change and percent change. The absolute and percent changes were calculated in four different ways. In method 1 the calculation was done for each vessel segment, so there were 114 values of absolute and percent change for each quantitative measure. For the remaining three methods, a single value was obtained for each of the 35 patients. In method 2 the results of measurements obtained for all quantitated vessel segments in the same patient were averaged together to yield a single patient result at baseline and 5 years later. In methods 3 and 4, a "most diseased" segment for each patient was selected as the single segment representing that patient. The most diseased segment was defined either by the largest percent diameter reduction in the initial study (method 3) or by the smallest ratio of the minimum to mean diameter in the initial study (method 4). Initial and follow- Changes in coronary measurements from the initial to the follow-up examination on a per segment basis are shown in table 3. Percent change was largest for percent coronary stenosis, but the change was highly variable, as reflected by the standard deviation. The t value was largest for absolute change in mean diameter (-0.12 -0.44; t = 5.8, p < .001). Changes in percent mean diameter (t = 5.1), absolute minimum diameter (t = 4.9), and percent minimum diameter (t = 3.4) were all highly significant (p < .001). The percent change in maximum diameter reduction also reached significance (t = 2.4, p < .02).
Coronary dimensional changes on a per patient basis over 5 years. Changes in coronary measuremients on a per patient basis are shown in tables 4 and 5. Based on a mean of all segments per patient (method 2), the largest percent change was noted in planar area of atheroma; however, the change in mean diameter was the most statistically significant (p < .001) because of the large standard deviation in the other measurements. Based on the segment with the greatest percent coronary stenosis on the initial study (method 3), absolute change in mean diameter again achieved the highest statistical significance (p < .01), but due to large standard deviations relative to the changes, statistically significant progression was noted in no other measurement. When the segment with the smallest minimum/mean diameter on the initial study was used as the index segment (method 4), again only progression of absolute change in mean diameter (p < .05) reached statistical significance because other measurements exhibited large standard deviations relative to their mean changes.
Change in "normal" reference diameter over 5 years.
The normal reference diameter decreased from 2.6 + 0.3 to 2.1 + 0.3 mm from initial to follow-up measurement (p < .01).
Number of patients required to demonstrate significant alteration in progression of coronary disease. Given a 0.21 ± 0.33 mm reduction in the mean segment diameter over 5 years without intervention for each patient (method 2; table 4), and assuming a 33% reduction in change with risk factor intervention, 467 patients would be required per treatment group to establish an interventional impact at the p < .05 level with 0.90 certainty. If one assumes a 50% reduction in change, 207 patients per group would be needed.
Discussion
Clinical trials of attempts to alter the progression of coronary artery disease require accurate and reproducible methods for assessing end points that ideally would show a high prevalence of change over a reasonable follow-up time period. Previous trials have found infarction and cardiac mortality to have a low annual incidence. Recently the Multiple Risk Factor Intervention Trial (MRFIT)4 found a yearly incidence of mor- Percent stenosis is a less than adequate marker of progression of coronary disease for a number of apparent reasons. Progression of atheromatous change in mild-to-moderately diseased vessels may occur in a diffuse manner involving the "normal" diameter used for comparison and rate of change may even exceed that in more severely stenotic areas. This is suggested by the observation of greater percent reduction in mean diameter when all segments, rather than only those with the most severe disease on baseline angiograms, were evaluated (tables 4 and 5). There is also a greater variability in progression of maximum percent stenosis than there is in mean diameter of given coronary segment. Finally, there are considerable difficulties in defining a permanent normal reference dimension, as reflected by the change in mean reference diameter from 2.6 + 0.3 mm on the initial study to 2.1 + 0.3 mm on the follow-up study.
The results of this study should be viewed with an understanding of several important design features. (1) Patients were reevaluated after 5 years of medical treatment and those who crossed over to surgery and who expired were necessarily excluded, thus creating a bias toward selection of patients likely to have had less progression of coronary artery disease.3' (2) The angiographic projections on initial and follow-up examinations were not exactly identical and most of the radiographic details were not recorded. (3) quality of film at the time baseline arteriograms were obtained was limited, and measurement errors were amplified as the ratio between residual luminal diameter and focal spot size diminished.
Although the quantitative method used in this study differs in its details from those reported by others,17 25 the magnitude and variation in dimensional change observed are unlikely to be substantially different. In view of our necessary exclusion of patients dying or requiring revascularization and the fact that presence of coronary risk factors were not a CASS selection criteria, we believe that this scenario for calculation of necessary sample size is conservative. If patients with more pronounced elevations of cholesterol level, blood pressure, or other risk factors were included, the required sample size would be even less.
In summary, the results of this study of 114 coronary segments from 35 patients treated medically for 5 years show that mean coronary dimension was the best measurement of progression of coronary artery disease, primarily because of its low coefficient of variation compared with measurements relative to a normal coronary diameter. Also, because of the low rate of disease progression, a sample population of approximately 470 per group would be required to show a 33% reduction in disease progression over a 5 year period with a power of 0.90.
